EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer

Kai Jie Yu, De Yi Ji, Ming Li Hsieh, Cheng Keng Chuang, See Tong Pang*, Wen Hui Weng*

*此作品的通信作者

研究成果: 期刊稿件文章同行評審

1 引文 斯高帕斯(Scopus)

摘要

It is known that miRNA-378a-3p (miR-378) could be induced by eicosapentaenoic acid (EPA), an omega-3 fatty acid. Herein, we first demonstrated how miR-378 exerts anti-prostate cancer (PCa) actions by influencing multiple target genes, including KLK2, KLK4, KLK6, and KLK14, which are implicated in PCa development, cell proliferation, and cell survival. Furthermore, these genes also correlate with androgen and mTOR signaling transduction, and are considered pivotal pathways for the onset and progression of PCa. In total, four PCa cell lines and eight pairing tissues (tumor vs. normal) from clinical PCa patients were included in the current study. The results showed high significance after EPA induced tumor cells containing higher expression levels of miR-378, and led the PCa cells having low cell viabilities, and they progressed to apoptosis when compared with normal prostate cells (p < 0.001). The findings indicated that EPA might become a potential therapy for PCa, especially because it is derived from the components of natural fish oil; it may prove to be a great help for solving the problem of castration-resistant prostate cancer (CRPC).

原文英語
文章編號2813
期刊Cancers
14
發行號11
DOIs
出版狀態已出版 - 01 06 2022

文獻附註

Publisher Copyright:
© 2022 by the authors. Licensee MDPI, Basel, Switzerland.

指紋

深入研究「EPA Modulates KLK Genes via miR-378: A Potential Therapy in Prostate Cancer」主題。共同形成了獨特的指紋。

引用此